Numerous studies have shown that down-regulation of GRN expression is associated with inflammation in multiple neurodegenerative diseases such as amyotrophic lateral sclerosis, frontotemporal dementia, Alzheimer's disease and Parkinson's disease (26). The gene discussed is GRN; the disease is neurodegenerative disease.